Lucid Diagnostics Inc. (LUCD)
undefined
undefined%
At close: undefined
0.76
-2.91%
After-hours Dec 13, 2024, 05:49 PM EST

Lucid Diagnostics Statistics

Share Statistics

Lucid Diagnostics has 59.34M shares outstanding. The number of shares has increased by 25.91% in one year.

Shares Outstanding 59.34M
Shares Change (YoY) n/a
Shares Change (QoQ) 3%
Owned by Institutions (%) n/a
Shares Floating 24.38M
Failed to Deliver (FTD) Shares 645
FTD / Avg. Volume 0.16%

Short Selling Information

The latest short interest is 422.42K, so 0.78% of the outstanding shares have been sold short.

Short Interest 422.42K
Short % of Shares Out 0.78%
Short % of Float 2.22%
Short Ratio (days to cover) 1.52

Valuation Ratios

The PE ratio is -1.12 and the forward PE ratio is -1.45.

PE Ratio -1.12
Forward PE -1.45
PS Ratio 24.25
Forward PS 3.1
PB Ratio -25.48
P/FCF Ratio -1.78
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Lucid Diagnostics Inc. has an Enterprise Value (EV) of 55.24M.

EV / Earnings -1.05
EV / Sales 22.75
EV / EBITDA -1.11
EV / EBIT -1.14
EV / FCF -1.67

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of -6.04.

Current Ratio 0.75
Quick Ratio 0.74
Debt / Equity -6.04
Total Debt / Capitalization 119.86
Cash Flow / Debt -2.35
Interest Coverage -116.54

Financial Efficiency

Return on equity (ROE) is 22.79% and return on capital (ROIC) is -374.55%.

Return on Equity (ROE) 22.79%
Return on Assets (ROA) -1.93%
Return on Capital (ROIC) -374.55%
Revenue Per Employee 34.69K
Profits Per Employee -752.37K
Employee Count 70
Asset Turnover 0.09
Inventory Turnover 21.51

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -40.46% in the last 52 weeks. The beta is 1.42, so Lucid Diagnostics 's price volatility has been higher than the market average.

Beta 1.42
52-Week Price Change -40.46%
50-Day Moving Average 0.91
200-Day Moving Average 0.88
Relative Strength Index (RSI) 28.6
Average Volume (20 Days) 408.18K

Income Statement

In the last 12 months, Lucid Diagnostics had revenue of $2.43M and earned -$52.67M in profits. Earnings per share was $-1.26.

Revenue 2.43M
Gross Profit -3.55M
Operating Income -48.48M
Net Income -52.67M
EBITDA -49.75M
EBIT -48.48M
Earnings Per Share (EPS) -1.26
Full Income Statement

Balance Sheet

The company has $18.90M in cash and $15.26M in debt, giving a net cash position of $3.64M.

Cash & Cash Equivalents 18.90M
Total Debt 15.26M
Net Cash 3.64M
Retained Earnings -150.74M
Total Assets 22.60M
Working Capital 2.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.82M and capital expenditures -$221.00K, giving a free cash flow of -$33.04M.

Operating Cash Flow -32.82M
Capital Expenditures -221.00K
Free Cash Flow -33.04M
FCF Per Share -0.79
Full Cash Flow Statement

Margins

Gross margin is -146.25%, with operating and profit margins of -2.00K% and -2.17K%.

Gross Margin -146.25%
Operating Margin -2.00K%
Pretax Margin -2.17K%
Profit Margin -2.17K%
EBITDA Margin -2.05K%
EBIT Margin -2.00K%
FCF Margin -1.36K%

Dividends & Yields

LUCD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -161.54%
FCF Yield -70.94%
Dividend Details

Analyst Forecast

The average price target for LUCD is $2.5, which is 220.5% higher than the current price. The consensus rating is "Buy".

Price Target $2.5
Price Target Difference 220.5%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Scores

Altman Z-Score -16.43
Piotroski F-Score 4